Neogen Key Executives
This section highlights Neogen's key executives, including their titles and compensation details.
Find Contacts at Neogen
(Showing 0 of )
Neogen Earnings
This section highlights Neogen's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
April 09, 2025
Time:
Before Market
Est. EPS:
$0.13
Status:
Unconfirmed
Last Earnings Results
Date:
January 10, 2025
EPS:
$0.11
Est. EPS:
$0.09
Revenue:
$231.26M
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q2 | 2025 | 2025-01-09 | N/A | N/A |
| Read Transcript | Q1 | 2025 | 2024-10-10 | $0.09 | $0.07 |
| Read Transcript | Q4 | 2024 | 2024-07-30 | $0.12 | $0.10 |
| Read Transcript | Q3 | 2024 | 2024-04-09 | $0.14 | $0.12 |
| Read Transcript | Q2 | 2024 | 2024-01-09 | $0.15 | $0.11 |
| Read Transcript | Q1 | 2024 | 2023-10-10 | $0.14 | $0.11 |
| Read Transcript | Q4 | 2023 | 2023-07-27 | $0.10 | $0.14 |
| Read Transcript | Q3 | 2023 | 2023-03-30 | $0.03 | $0.12 |
| Read Transcript | Q2 | 2023 | 2023-01-05 | $-0.08 | $0.15 |
| Read Transcript | Q1 | 2023 | 2022-09-27 | $0.16 | $0.15 |
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Healthcare
Medical - Diagnostics & Research
$8.45
Stock Price
$1.83B
Market Cap
2.92K
Employees
Lansing, MI
Location
Financial Statements
Access annual & quarterly financial statements for Neogen, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | May 31, 2024 | May 31, 2023 | May 31, 2022 | May 31, 2021 | May 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $924.22M | $822.45M | $527.16M | $468.46M | $418.17M |
| Cost of Revenue | $460.32M | $416.49M | $284.15M | $253.40M | $221.89M |
| Gross Profit | $463.90M | $405.95M | $243.01M | $215.06M | $196.28M |
| Gross Profit Ratio | 50.19% | 49.40% | 46.10% | 45.90% | 46.94% |
| Research and Development Expenses | $22.48M | $26.04M | $17.05M | $16.25M | $14.75M |
| General and Administrative Expenses | $199.89M | $201.18M | $82.74M | $51.20M | $44.33M |
| Selling and Marketing Expenses | $182.87M | $141.22M | $84.60M | $73.44M | $69.67M |
| Selling General and Administrative Expenses | $382.76M | $342.40M | $167.35M | $124.64M | $114.01M |
| Other Expenses | $- | $-59.56M | $1.59M | $1.10M | $4.78M |
| Operating Expenses | $405.24M | $368.44M | $184.40M | $140.89M | $128.76M |
| Cost and Expenses | $865.56M | $784.93M | $468.54M | $394.29M | $350.65M |
| Interest Income | $6.36M | $3.17M | $1.27M | $1.61M | $5.99M |
| Interest Expense | $73.39M | $55.96M | $1.27M | $78.00K | $- |
| Depreciation and Amortization | $121.23M | $88.38M | $23.69M | $21.04M | $18.40M |
| EBITDA | $182.60M | $122.30M | $107.89M | $98.30M | $85.92M |
| EBITDA Ratio | 19.76% | 4.56% | 11.12% | 15.83% | 16.15% |
| Operating Income | $58.66M | $37.52M | $34.92M | $53.13M | $49.13M |
| Operating Income Ratio | 6.35% | 4.56% | 6.62% | 11.34% | 11.75% |
| Total Other Income Expenses Net | $-72.97M | $-59.56M | $1.59M | $1.10M | $4.78M |
| Income Before Tax | $-14.30M | $-22.04M | $60.21M | $75.27M | $72.31M |
| Income Before Tax Ratio | -1.55% | -2.68% | 11.42% | 16.07% | 17.29% |
| Income Tax Expense | $-4.88M | $828.00K | $11.90M | $14.39M | $12.83M |
| Net Income | $-9.42M | $-22.87M | $48.31M | $60.88M | $59.48M |
| Net Income Ratio | -1.02% | -2.78% | 9.16% | 13.00% | 14.22% |
| EPS | $-0.04 | $-0.12 | $0.45 | $0.57 | $0.57 |
| EPS Diluted | $-0.04 | $-0.12 | $0.45 | $0.57 | $0.56 |
| Weighted Average Shares Outstanding | 216.48M | 188.88M | 107.68M | 106.50M | 105.10M |
| Weighted Average Shares Outstanding Diluted | 216.48M | 188.88M | 108.02M | 107.12M | 105.72M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | November 30, 2024 | August 31, 2024 | May 31, 2024 | February 29, 2024 | November 30, 2023 | August 31, 2023 | May 31, 2023 | February 28, 2023 | November 30, 2022 | August 31, 2022 | May 31, 2022 | February 28, 2022 | November 30, 2021 | August 31, 2021 | May 31, 2021 | February 28, 2021 | November 30, 2020 | August 31, 2020 | May 31, 2020 | February 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $231.26M | $216.96M | $236.79M | $228.81M | $229.63M | $228.99M | $241.81M | $218.25M | $230.03M | $132.35M | $140.09M | $128.24M | $130.52M | $128.31M | $127.42M | $116.71M | $115.00M | $109.33M | $109.07M | $99.87M |
| Cost of Revenue | $117.93M | $112.04M | $123.31M | $111.93M | $112.86M | $112.23M | $118.63M | $110.29M | $117.49M | $70.08M | $75.09M | $70.83M | $69.92M | $68.30M | $69.73M | $62.86M | $61.79M | $59.02M | $57.34M | $54.54M |
| Gross Profit | $113.33M | $104.93M | $113.48M | $116.88M | $116.77M | $116.76M | $123.18M | $107.96M | $112.54M | $62.27M | $65.00M | $57.41M | $60.59M | $60.01M | $57.69M | $53.85M | $53.21M | $50.30M | $51.73M | $45.33M |
| Gross Profit Ratio | 49.01% | 48.40% | 47.90% | 51.10% | 50.90% | 51.00% | 50.90% | 49.50% | 48.90% | 47.00% | 46.40% | 44.80% | 46.40% | 46.80% | 45.30% | 46.10% | 46.30% | 46.00% | 47.43% | 45.39% |
| Research and Development Expenses | $5.11M | $5.20M | $5.14M | $4.85M | $5.76M | $6.72M | $7.05M | $7.26M | $6.85M | $4.88M | $3.83M | $4.56M | $4.33M | $4.33M | $4.08M | $4.24M | $4.06M | $3.88M | $3.46M | $3.82M |
| General and Administrative Expenses | $57.77M | $51.67M | $50.96M | $52.09M | $51.72M | $45.12M | $49.81M | $46.42M | $77.00M | $27.94M | $21.76M | $25.00M | $22.61M | $13.38M | $12.85M | $15.15M | $12.18M | $11.01M | $11.86M | $10.79M |
| Selling and Marketing Expenses | $46.55M | $45.80M | $44.34M | $47.92M | $44.83M | $45.78M | $42.89M | $38.60M | $36.35M | $23.38M | $21.38M | $21.48M | $21.19M | $20.55M | $20.50M | $18.69M | $17.73M | $16.52M | $16.47M | $17.68M |
| Selling General and Administrative Expenses | $104.32M | $97.47M | $90.77M | $100.01M | $96.55M | $90.90M | $92.70M | $85.02M | $113.35M | $51.33M | $43.14M | $46.47M | $43.79M | $33.94M | $33.36M | $33.84M | $29.91M | $27.53M | $28.33M | $28.46M |
| Other Expenses | $461.39M | $- | $-5.73M | $-265.00K | $179.00K | $-17.47M | $-15.78M | $-151.00K | $- | $597.00K | $882.00K | $266.00K | $459.00K | $-18.00K | $-109.00K | $203.00K | $90.00K | $915.00K | $1.23M | $1.21M |
| Operating Expenses | $570.81M | $102.67M | $95.91M | $104.86M | $102.31M | $97.63M | $99.76M | $92.28M | $120.19M | $56.21M | $46.97M | $51.03M | $48.12M | $38.26M | $37.44M | $38.08M | $33.97M | $31.41M | $31.79M | $32.29M |
| Cost and Expenses | $688.74M | $214.71M | $219.22M | $216.79M | $215.16M | $209.85M | $218.38M | $202.57M | $237.69M | $126.29M | $122.07M | $121.87M | $118.05M | $106.56M | $107.17M | $100.94M | $95.75M | $90.43M | $89.13M | $86.83M |
| Interest Income | $774.00K | $993.00K | $1.10M | $1.61M | $1.86M | $1.79M | $1.00M | $640.00K | $553.00K | $969.00K | $526.00K | $314.00K | $224.00K | $203.00K | $43.00K | $294.00K | $555.00K | $722.00K | $1.61M | $1.60M |
| Interest Expense | $18.14M | $18.61M | $18.62M | $18.29M | $18.03M | $18.46M | $17.95M | $17.46M | $20.55M | $- | $526.00K | $314.00K | $- | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $- | $29.80M | $28.86M | $29.65M | $29.47M | $28.73M | $28.44M | $27.47M | $26.74M | $5.73M | $5.86M | $6.32M | $5.83M | $5.68M | $5.93M | $5.58M | $4.80M | $4.72M | $4.85M | $4.56M |
| EBITDA | $-457.48M | $32.81M | $41.67M | $41.67M | $48.52M | $49.09M | $117.03M | $43.16M | $13.19M | $25.52M | $23.89M | $12.70M | $27.60M | $27.43M | $26.19M | $21.36M | $24.05M | $23.61M | $24.80M | $17.60M |
| EBITDA Ratio | -197.82% | 15.12% | 19.61% | 18.80% | 20.02% | 20.90% | 9.69% | 7.19% | 5.73% | 4.58% | 12.87% | 4.97% | 9.55% | 16.95% | 15.90% | 13.52% | 16.73% | 17.28% | 18.28% | 13.06% |
| Operating Income | $-457.48M | $2.26M | $17.57M | $12.02M | $14.46M | $19.14M | $23.43M | $-11.79M | $-7.66M | $6.06M | $12.17M | $55.00K | $12.47M | $21.75M | $20.25M | $15.77M | $19.25M | $18.89M | $19.94M | $13.04M |
| Operating Income Ratio | -197.82% | 1.04% | 7.42% | 5.25% | 6.30% | 8.36% | 9.69% | -5.40% | -3.33% | 4.58% | 8.68% | 0.04% | 9.55% | 16.95% | 15.90% | 13.52% | 16.73% | 17.28% | 18.28% | 13.06% |
| Total Other Income Expenses Net | $-19.09M | $-17.87M | $-19.44M | $-17.84M | $-18.21M | $-17.47M | $-15.78M | $-17.94M | $-26.43M | $597.00K | $882.00K | $266.00K | $459.00K | $-18.00K | $-109.00K | $203.00K | $90.00K | $915.00K | $1.23M | $1.21M |
| Income Before Tax | $-476.57M | $-15.61M | $-6.40M | $-5.82M | $-3.75M | $1.66M | $7.65M | $-2.26M | $-34.09M | $6.66M | $18.91M | $6.64M | $12.93M | $21.73M | $20.15M | $15.98M | $19.34M | $19.81M | $21.18M | $14.25M |
| Income Before Tax Ratio | -206.08% | -7.19% | -2.70% | -2.54% | -1.63% | 0.73% | 3.16% | -1.04% | -14.82% | 5.03% | 13.50% | 5.18% | 9.91% | 16.93% | 15.81% | 13.69% | 16.81% | 18.12% | 19.42% | 14.27% |
| Income Tax Expense | $-20.29M | $-3.00M | $-984.00K | $-3.80M | $-260.00K | $160.00K | $2.08M | $-10.45M | $7.75M | $1.45M | $3.95M | $1.20M | $2.10M | $4.65M | $4.39M | $2.60M | $3.45M | $3.95M | $4.83M | $2.05M |
| Net Income | $-456.28M | $-12.61M | $-5.42M | $-2.02M | $-3.49M | $1.50M | $5.57M | $8.19M | $-41.84M | $5.21M | $14.96M | $5.44M | $10.83M | $17.08M | $15.76M | $13.38M | $15.88M | $15.86M | $16.35M | $12.20M |
| Net Income Ratio | -197.30% | -5.81% | -2.29% | -0.88% | -1.52% | 0.66% | 2.30% | 3.75% | -18.19% | 3.94% | 10.68% | 4.24% | 8.30% | 13.31% | 12.37% | 11.46% | 13.81% | 14.51% | 14.99% | 12.22% |
| EPS | $-4.27 | $-0.06 | $-0.03 | $-0.01 | $-0.02 | $0.01 | $0.03 | $0.04 | $-0.19 | $0.05 | $0.14 | $0.05 | $0.10 | $0.16 | $0.15 | $0.12 | $0.15 | $0.15 | $0.15 | $0.12 |
| EPS Diluted | $-4.27 | $-0.06 | $-0.03 | $-0.01 | $-0.02 | $0.01 | $0.03 | $0.04 | $-0.19 | $0.05 | $0.14 | $0.05 | $0.10 | $0.16 | $0.15 | $0.12 | $0.15 | $0.15 | $0.15 | $0.12 |
| Weighted Average Shares Outstanding | 216.81M | 216.70M | 216.61M | 216.60M | 216.41M | 216.31M | 216.25M | 216.22M | 216.14M | 107.84M | 107.79M | 107.82M | 107.77M | 107.49M | 107.47M | 107.02M | 106.26M | 106.08M | 106.24M | 105.82M |
| Weighted Average Shares Outstanding Diluted | 216.81M | 216.70M | 216.61M | 216.60M | 216.41M | 216.85M | 216.44M | 216.40M | 220.22M | 107.86M | 107.86M | 108.13M | 108.12M | 108.11M | 108.04M | 107.39M | 106.49M | 106.57M | 106.24M | 106.09M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | May 31, 2024 | May 31, 2023 | May 31, 2022 | May 31, 2021 | May 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $170.61M | $163.24M | $381.05M | $381.09M | $343.67M |
| Short Term Investments | $325.00K | $82.33M | $336.58M | $305.49M | $277.40M |
| Cash and Short Term Investments | $170.94M | $245.57M | $381.05M | $381.09M | $343.67M |
| Net Receivables | $173.00M | $153.25M | $99.67M | $91.82M | $84.68M |
| Inventory | $189.27M | $133.81M | $122.31M | $100.70M | $95.05M |
| Other Current Assets | $56.02M | $53.30M | $47.52M | $35.68M | $28.00M |
| Total Current Assets | $589.23M | $585.93M | $626.80M | $591.45M | $537.41M |
| Property Plant Equipment Net | $291.89M | $198.75M | $110.58M | $100.45M | $78.67M |
| Goodwill | $2.14B | $3.77B | $255.55M | $228.29M | $181.10M |
| Intangible Assets | $1.51B | $1.61B | $107.50M | $92.32M | $66.58M |
| Goodwill and Intangible Assets | $3.65B | $3.77B | $255.55M | $228.29M | $181.10M |
| Long Term Investments | $229.00K | $-34.61M | $-9.08M | $-5.89M | $-5.77M |
| Tax Assets | $- | $19.39M | $6.93M | $3.88M | $3.54M |
| Other Non-Current Assets | $20.20M | $15.22M | $2.16M | $2.02M | $2.23M |
| Total Non-Current Assets | $3.96B | $3.97B | $366.13M | $328.74M | $259.78M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $4.55B | $4.55B | $992.93M | $920.19M | $797.18M |
| Account Payables | $83.06M | $76.67M | $34.61M | $23.90M | $25.65M |
| Short Term Debt | $7.55M | $- | $- | $1.28M | $1.05M |
| Tax Payables | $10.45M | $6.95M | $2.13M | $1.85M | $1.46M |
| Deferred Revenue | $4.63M | $4.62M | $5.46M | $3.40M | $-1.05M |
| Other Current Liabilities | $48.63M | $57.24M | $35.64M | $26.57M | $20.33M |
| Total Current Liabilities | $154.32M | $145.47M | $77.84M | $53.60M | $48.49M |
| Long Term Debt | $898.69M | $894.25M | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $-353.43M | $17.01M | $-1.21M | $-913.00K |
| Deferred Tax Liabilities Non-Current | $- | $353.43M | $17.01M | $21.92M | $18.12M |
| Other Non-Current Liabilities | $351.68M | $27.07M | $27.71M | $26.22M | $23.52M |
| Total Non-Current Liabilities | $1.25B | $1.27B | $27.71M | $26.22M | $23.52M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $1.40B | $1.42B | $105.56M | $79.81M | $72.00M |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $34.66M | $34.60M | $17.25M | $17.20M | $8.47M |
| Retained Earnings | $555.62M | $565.04M | $587.91M | $539.60M | $478.72M |
| Accumulated Other Comprehensive Income Loss | $-30.02M | $-33.25M | $-27.77M | $-11.38M | $-19.71M |
| Other Total Stockholders Equity | $2.58B | $2.57B | $309.98M | $294.95M | $249.22M |
| Total Stockholders Equity | $3.14B | $3.13B | $887.37M | $840.38M | $725.18M |
| Total Equity | $3.14B | $3.13B | $887.37M | $840.38M | $725.18M |
| Total Liabilities and Stockholders Equity | $4.55B | $4.55B | $992.93M | $920.19M | $797.18M |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $4.55B | $4.55B | $992.93M | $920.19M | $797.18M |
| Total Investments | $554.00K | $82.33M | $336.58M | $305.49M | $277.40M |
| Total Debt | $906.24M | $900.00M | $986.69M | $1.29M | $1.05M |
| Net Debt | $735.63M | $736.76M | $605.64M | $-379.80M | $-342.62M |
Balance Sheet Charts
| Breakdown | November 30, 2024 | August 31, 2024 | May 31, 2024 | February 29, 2024 | November 30, 2023 | August 31, 2023 | May 31, 2023 | February 28, 2023 | November 30, 2022 | August 31, 2022 | May 31, 2022 | February 28, 2022 | November 30, 2021 | August 31, 2021 | May 31, 2021 | February 28, 2021 | November 30, 2020 | August 31, 2020 | May 31, 2020 | February 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $140.23M | $120.48M | $170.61M | $161.44M | $205.76M | $178.83M | $163.24M | $67.13M | $100.00M | $347.71M | $381.05M | $378.44M | $389.25M | $400.88M | $381.09M | $353.35M | $390.76M | $367.49M | $343.67M | $327.92M |
| Short Term Investments | $- | $- | $325.00K | $7.01M | $24.50M | $60.42M | $82.33M | $116.08M | $176.34M | $240.61M | $336.58M | $335.56M | $338.13M | $329.60M | $305.49M | $279.87M | $276.90M | $306.54M | $277.40M | $277.15M |
| Cash and Short Term Investments | $140.23M | $120.48M | $170.94M | $168.45M | $230.27M | $239.26M | $245.57M | $183.21M | $276.34M | $347.71M | $381.05M | $378.44M | $389.25M | $400.88M | $381.09M | $353.35M | $390.76M | $367.49M | $343.67M | $327.92M |
| Net Receivables | $164.09M | $167.64M | $173.00M | $173.59M | $150.50M | $137.67M | $153.25M | $146.39M | $142.71M | $93.11M | $99.67M | $92.98M | $92.50M | $87.29M | $91.82M | $87.24M | $79.93M | $77.69M | $84.68M | $80.69M |
| Inventory | $198.27M | $198.60M | $189.27M | $182.39M | $160.53M | $140.69M | $133.81M | $143.86M | $136.07M | $129.04M | $122.31M | $113.39M | $107.09M | $102.11M | $100.70M | $99.27M | $92.53M | $97.57M | $95.05M | $89.24M |
| Other Current Assets | $67.86M | $53.94M | $56.02M | $78.04M | $83.08M | $66.18M | $53.30M | $81.90M | $88.22M | $76.09M | $47.52M | $24.82M | $22.37M | $37.69M | $35.68M | $30.90M | $30.40M | $13.96M | $28.00M | $34.03M |
| Total Current Assets | $570.45M | $540.65M | $589.23M | $602.47M | $624.37M | $583.79M | $585.93M | $555.37M | $643.33M | $607.91M | $626.80M | $608.33M | $609.95M | $609.12M | $591.45M | $555.30M | $578.43M | $556.70M | $537.41M | $514.88M |
| Property Plant Equipment Net | $327.75M | $315.28M | $291.89M | $287.58M | $259.31M | $235.59M | $198.75M | $164.89M | $151.88M | $121.02M | $110.58M | $104.70M | $100.86M | $99.52M | $100.45M | $97.98M | $83.77M | $80.59M | $78.67M | $78.39M |
| Goodwill | $1.67B | $2.14B | $2.14B | $2.14B | $2.14B | $2.14B | $3.77B | $3.79B | $2.12B | $248.48M | $255.55M | $266.87M | $255.87M | $223.47M | $228.29M | $226.93M | $183.43M | $184.30M | $181.10M | $180.23M |
| Intangible Assets | $1.46B | $1.49B | $1.51B | $1.54B | $1.56B | $1.59B | $1.61B | $1.63B | $1.64B | $103.42M | $107.50M | $112.06M | $109.06M | $89.03M | $92.32M | $92.63M | $70.20M | $70.87M | $66.58M | $70.47M |
| Goodwill and Intangible Assets | $3.14B | $3.63B | $3.65B | $3.68B | $3.70B | $3.73B | $3.77B | $3.79B | $3.76B | $248.48M | $255.55M | $266.87M | $255.87M | $223.47M | $228.29M | $226.93M | $183.43M | $184.30M | $181.10M | $180.23M |
| Long Term Investments | $- | $- | $229.00K | $-353.85M | $-355.00M | $-354.79M | $-34.61M | $- | $- | $- | $-9.08M | $-23.21M | $-23.85M | $-23.84M | $-5.89M | $- | $-54.82M | $-55.50M | $- | $- |
| Tax Assets | $- | $- | $35.33M | $353.85M | $355.00M | $354.79M | $19.39M | $362.63M | $- | $- | $6.93M | $21.20M | $21.83M | $21.83M | $3.88M | $- | $18.39M | $18.31M | $- | $- |
| Other Non-Current Assets | $20.23M | $20.00M | $20.20M | $16.36M | $16.00M | $16.05M | $15.22M | $-362.63M | $3.90M | $- | $2.16M | $2.02M | $2.02M | $2.02M | $-3.88M | $- | $36.43M | $37.20M | $- | $- |
| Total Non-Current Assets | $3.48B | $3.96B | $3.99B | $3.98B | $3.98B | $3.98B | $3.97B | $3.95B | $3.92B | $369.50M | $366.13M | $371.57M | $356.73M | $322.98M | $328.74M | $324.91M | $267.20M | $264.89M | $259.78M | $258.63M |
| Other Assets | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $4.05B | $4.50B | $4.58B | $4.58B | $4.60B | $4.56B | $4.55B | $4.51B | $4.56B | $977.40M | $992.93M | $979.90M | $966.68M | $932.11M | $920.19M | $880.22M | $845.63M | $821.59M | $797.18M | $773.50M |
| Account Payables | $79.57M | $61.46M | $83.06M | $89.75M | $112.18M | $90.21M | $76.67M | $60.49M | $79.25M | $27.00M | $34.61M | $23.55M | $34.22M | $22.41M | $23.90M | $23.26M | $20.70M | $22.54M | $25.65M | $18.99M |
| Short Term Debt | $2.58M | $2.65M | $7.55M | $2.52M | $2.57M | $2.64M | $- | $- | $- | $- | $- | $- | $- | $- | $1.28M | $- | $- | $- | $1.05M | $- |
| Tax Payables | $11.18M | $11.10M | $10.45M | $11.57M | $10.22M | $5.40M | $6.95M | $1.65M | $9.05M | $3.92M | $2.13M | $- | $- | $4.52M | $1.85M | $- | $476.00K | $4.60M | $1.46M | $1.48M |
| Deferred Revenue | $5.65M | $5.63M | $4.63M | $5.49M | $4.68M | $3.79M | $4.62M | $6.76M | $5.08M | $5.46M | $5.46M | $- | $- | $- | $-1.28M | $- | $- | $- | $- | $- |
| Other Current Liabilities | $52.22M | $41.84M | $53.73M | $48.52M | $46.96M | $36.09M | $57.24M | $38.25M | $59.17M | $30.62M | $35.64M | $42.16M | $28.45M | $23.82M | $26.57M | $22.68M | $23.41M | $19.31M | $20.33M | $18.66M |
| Total Current Liabilities | $151.19M | $122.69M | $154.32M | $157.84M | $176.61M | $138.13M | $145.47M | $107.16M | $152.56M | $67.00M | $77.84M | $64.40M | $61.42M | $50.76M | $53.60M | $45.94M | $44.59M | $46.44M | $48.49M | $39.13M |
| Long Term Debt | $889.87M | $889.13M | $898.69M | $887.65M | $886.91M | $886.18M | $894.25M | $889.81M | $923.96M | $- | $- | $- | $- | $- | $1.21M | $1.09M | $1.06M | $966.00K | $913.00K | $1.47M |
| Deferred Revenue Non-Current | $- | $- | $10.30M | $- | $- | $- | $- | $362.63M | $- | $- | $- | $-2.78M | $-2.18M | $-2.41M | $-1.21M | $-1.09M | $-1.06M | $-966.00K | $-913.00K | $-1.47M |
| Deferred Tax Liabilities Non-Current | $302.40M | $317.57M | $362.05M | $353.85M | $355.00M | $354.79M | $353.43M | $362.63M | $364.25M | $15.95M | $17.01M | $21.20M | $21.83M | $21.83M | $21.92M | $21.28M | $18.39M | $18.31M | $18.12M | $16.34M |
| Other Non-Current Liabilities | $41.55M | $38.59M | $24.96M | $36.97M | $36.32M | $35.83M | $27.07M | $23.61M | $16.21M | $10.65M | $27.71M | $18.75M | $17.96M | $4.15M | $25.01M | $4.23M | $4.19M | $4.33M | $22.60M | $4.68M |
| Total Non-Current Liabilities | $1.23B | $1.25B | $1.29B | $1.28B | $1.28B | $1.28B | $1.27B | $1.28B | $1.30B | $26.60M | $27.71M | $39.95M | $39.78M | $25.98M | $26.22M | $26.59M | $23.64M | $23.60M | $23.52M | $22.50M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $1.39B | $1.37B | $1.44B | $1.44B | $1.45B | $1.41B | $1.42B | $1.38B | $1.46B | $93.61M | $105.56M | $104.35M | $101.20M | $76.74M | $79.81M | $72.53M | $68.23M | $70.05M | $72.00M | $61.63M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $34.71M | $34.67M | $34.66M | $34.66M | $34.64M | $34.61M | $34.60M | $34.59M | $34.58M | $17.25M | $17.25M | $17.25M | $17.24M | $17.20M | $17.20M | $8.56M | $8.52M | $8.49M | $8.47M | $8.47M |
| Retained Earnings | $86.73M | $543.01M | $555.62M | $561.03M | $563.06M | $566.54M | $565.04M | $559.47M | $551.28M | $593.12M | $587.91M | $572.95M | $567.51M | $556.68M | $539.60M | $523.84M | $510.47M | $494.58M | $478.72M | $462.38M |
| Accumulated Other Comprehensive Income Loss | $-44.74M | $-31.42M | $-30.02M | $-29.47M | $-25.13M | $-26.50M | $-33.25M | $-33.22M | $-40.50M | $-39.33M | $-27.77M | $-22.44M | $-24.23M | $-16.20M | $-11.38M | $-14.84M | $-15.09M | $-15.71M | $-19.71M | $-13.51M |
| Other Total Stockholders Equity | $2.59B | $2.59B | $2.58B | $2.58B | $2.57B | $2.57B | $2.57B | $2.56B | $2.56B | $312.75M | $309.98M | $307.78M | $304.96M | $297.69M | $294.95M | $290.12M | $273.50M | $264.18M | $249.22M | $254.54M |
| Total Stockholders Equity | $2.67B | $3.14B | $3.14B | $3.15B | $3.15B | $3.15B | $3.13B | $3.13B | $3.11B | $883.80M | $887.37M | $875.54M | $865.48M | $855.36M | $840.38M | $807.68M | $777.39M | $751.55M | $725.18M | $711.87M |
| Total Equity | $2.67B | $3.14B | $3.14B | $3.15B | $3.15B | $3.15B | $3.13B | $3.13B | $3.11B | $883.80M | $887.37M | $875.54M | $865.48M | $855.36M | $840.38M | $807.68M | $777.39M | $751.55M | $725.18M | $711.87M |
| Total Liabilities and Stockholders Equity | $4.05B | $4.50B | $4.58B | $4.58B | $4.60B | $4.56B | $4.55B | $4.51B | $4.56B | $977.40M | $992.93M | $979.90M | $966.68M | $932.11M | $920.19M | $880.22M | $845.63M | $821.59M | $797.18M | $773.50M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $4.05B | $4.50B | $4.58B | $4.58B | $4.60B | $4.56B | $4.55B | $4.51B | $4.56B | $977.40M | $992.93M | $979.90M | $966.68M | $932.11M | $920.19M | $880.22M | $845.63M | $821.59M | $797.18M | $773.50M |
| Total Investments | $- | $317.00K | $554.00K | $7.01M | $24.50M | $60.42M | $82.33M | $116.08M | $176.34M | $240.61M | $336.58M | $335.56M | $338.13M | $329.60M | $305.49M | $279.87M | $276.90M | $306.54M | $277.40M | $277.15M |
| Total Debt | $892.44M | $891.78M | $906.24M | $890.17M | $889.48M | $888.82M | $885.44M | $884.70M | $923.96M | $- | $986.69M | $2.78M | $2.18M | $2.41M | $1.29M | $1.09M | $1.06M | $966.00K | $913.00K | $1.47M |
| Net Debt | $752.21M | $771.30M | $735.63M | $728.74M | $683.72M | $709.99M | $722.20M | $817.57M | $823.96M | $-347.71M | $605.64M | $-375.66M | $-387.07M | $-398.47M | $-379.80M | $-352.26M | $-389.70M | $-366.52M | $-342.76M | $-326.46M |
Annual Cash Flow
| Breakdown | May 31, 2024 | May 31, 2023 | May 31, 2022 | May 31, 2021 | May 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $-9.42M | $-22.87M | $48.31M | $60.88M | $59.48M |
| Depreciation and Amortization | $121.23M | $88.38M | $23.69M | $21.04M | $18.40M |
| Deferred Income Tax | $-27.42M | $-19.23M | $-4.70M | $-640.00K | $1.60M |
| Stock Based Compensation | $13.77M | $10.18M | $7.15M | $6.44M | $6.47M |
| Change in Working Capital | $-72.68M | $-22.79M | $-6.42M | $-6.63M | $-62.00K |
| Accounts Receivables | $-20.10M | $-53.88M | $-7.80M | $-2.60M | $-2.88M |
| Inventory | $-55.95M | $9.96M | $-21.07M | $2.45M | $-10.01M |
| Accounts Payables | $13.75M | $18.64M | $10.21M | $-3.21M | $6.75M |
| Other Working Capital | $-10.38M | $2.50M | $12.23M | $-3.28M | $6.08M |
| Other Non Cash Items | $9.80M | $7.36M | $73.20M | $51.87M | $49.41M |
| Net Cash Provided by Operating Activities | $35.26M | $41.03M | $68.04M | $81.09M | $85.88M |
| Investments in Property Plant and Equipment | $-111.42M | $-65.76M | $-24.43M | $-26.71M | $-24.05M |
| Acquisitions Net | $- | $11.72M | $-38.74M | $-50.77M | $-13.16M |
| Purchases of Investments | $- | $-12.52M | $-415.89M | $-792.68M | $-458.30M |
| Sales Maturities of Investments | $82.00M | $266.77M | $381.84M | $764.60M | $406.73M |
| Other Investing Activities | $108.00K | $826.00K | $-34.05M | $-28.08M | $-51.57M |
| Net Cash Used for Investing Activities | $-29.31M | $201.04M | $-97.23M | $-105.56M | $-88.78M |
| Debt Repayment | $- | $-100.00M | $- | $- | $- |
| Common Stock Issued | $2.46M | $- | $7.93M | $34.63M | $29.41M |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $1.92M | $-19.28M | $6.81M | $33.54M | $29.41M |
| Net Cash Used Provided by Financing Activities | $1.92M | $-118.08M | $6.81M | $33.54M | $29.41M |
| Effect of Forex Changes on Cash | $-502.00K | $-5.22M | $-8.75M | $264.00K | $-1.92M |
| Net Change in Cash | $7.37M | $118.77M | $-31.13M | $9.33M | $24.58M |
| Cash at End of Period | $170.61M | $163.24M | $44.47M | $75.60M | $66.27M |
| Cash at Beginning of Period | $163.24M | $44.47M | $75.60M | $66.27M | $41.69M |
| Operating Cash Flow | $35.26M | $41.03M | $68.04M | $81.09M | $85.88M |
| Capital Expenditure | $-111.42M | $-65.76M | $-24.43M | $-26.71M | $-24.05M |
| Free Cash Flow | $-76.16M | $-24.73M | $43.61M | $54.38M | $61.83M |
Cash Flow Charts
| Breakdown | November 30, 2024 | August 31, 2024 | May 31, 2024 | February 29, 2024 | November 30, 2023 | August 31, 2023 | May 31, 2023 | February 28, 2023 | November 30, 2022 | August 31, 2022 | May 31, 2022 | February 28, 2022 | November 30, 2021 | August 31, 2021 | May 31, 2021 | February 28, 2021 | November 30, 2020 | August 31, 2020 | May 31, 2020 | February 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-456.28M | $-12.61M | $-5.42M | $-2.02M | $-3.49M | $1.50M | $5.57M | $8.19M | $-41.84M | $5.21M | $14.96M | $5.44M | $10.83M | $17.08M | $15.76M | $13.38M | $15.88M | $15.86M | $16.35M | $12.20M |
| Depreciation and Amortization | $30.05M | $29.80M | $28.86M | $29.65M | $29.47M | $28.73M | $28.44M | $27.47M | $26.74M | $5.73M | $5.86M | $6.32M | $5.83M | $5.68M | $5.93M | $5.58M | $4.80M | $4.72M | $4.85M | $4.56M |
| Deferred Income Tax | $-14.80M | $-9.12M | $-27.52M | $-1.08M | $180.00K | $998.00K | $-13.93M | $-3.32M | $-544.00K | $-1.44M | $-4.70M | $- | $- | $- | $-640.00K | $- | $- | $- | $1.60M | $- |
| Stock Based Compensation | $4.82M | $3.98M | $3.94M | $3.68M | $3.51M | $2.64M | $2.87M | $2.81M | $2.63M | $1.87M | $2.11M | $1.61M | $1.75M | $1.69M | $1.66M | $1.58M | $1.51M | $1.68M | $1.67M | $1.64M |
| Change in Working Capital | $30.64M | $-30.64M | $15.84M | $-61.23M | $-15.57M | $-11.72M | $65.86M | $-57.89M | $-6.25M | $-25.51M | $2.16M | $-6.78M | $-558.00K | $-1.24M | $-749.00K | $-8.95M | $191.00K | $2.87M | $1.15M | $1.38M |
| Accounts Receivables | $536.00K | $4.80M | $-3.96M | $-19.77M | $-12.61M | $16.24M | $-6.34M | $-3.08M | $-49.27M | $4.82M | $-6.92M | $617.00K | $-5.54M | $4.04M | $-3.61M | $-5.64M | $-1.69M | $8.35M | $-6.72M | $6.32M |
| Inventory | $-7.46M | $-9.94M | $-7.29M | $-22.73M | $-19.62M | $-6.30M | $10.61M | $-7.13M | $14.81M | $-8.33M | $-9.12M | $-5.03M | $-5.07M | $-1.86M | $-878.00K | $-735.00K | $5.38M | $-1.32M | $-7.77M | $-2.13M |
| Accounts Payables | $18.05M | $-15.88M | $-7.63M | $-13.56M | $29.97M | $4.98M | $27.06M | $-38.49M | $37.38M | $-7.32M | $2.13M | $-2.26M | $12.72M | $-2.38M | $5.12M | $-2.74M | $-2.47M | $-3.11M | $6.44M | $-1.01M |
| Other Working Capital | $19.52M | $-9.62M | $34.73M | $-5.16M | $-13.31M | $-26.64M | $34.53M | $-9.18M | $-9.17M | $-8.72M | $16.06M | $-115.00K | $-2.68M | $-1.03M | $-1.37M | $172.00K | $-1.03M | $-1.04M | $9.20M | $-1.80M |
| Other Non Cash Items | $445.83M | $676.00K | $91.50M | $795.00K | $1.61M | $860.00K | $2.15M | $5.66M | $543.00K | $-14.72M | $27.73M | $20.92M | $11.28M | $13.26M | $-640.00K | $-2.74M | $-2.47M | $-3.11M | $1.60M | $-1.01M |
| Net Cash Provided by Operating Activities | $40.25M | $-17.91M | $26.65M | $-30.21M | $15.71M | $23.01M | $90.97M | $-17.07M | $-18.73M | $-14.14M | $20.39M | $6.59M | $17.85M | $23.21M | $21.97M | $11.60M | $22.39M | $25.13M | $25.63M | $19.78M |
| Investments in Property Plant and Equipment | $38.43M | $-38.43M | $-24.25M | $-32.12M | $-24.42M | $-30.63M | $-25.50M | $-15.15M | $-12.11M | $-13.00M | $-12.54M | $-6.66M | $-3.94M | $-1.29M | $-7.32M | $-8.30M | $-6.84M | $-4.25M | $-7.73M | $-3.52M |
| Acquisitions Net | $- | $- | $46.00K | $-8.00K | $29.00K | $41.00K | $-1.52M | $-25.66M | $40.23M | $-1.33M | $-581.00K | $-11.30M | $-26.86M | $1.29M | $1.23M | $-49.65M | $- | $-2.35M | $-3.46M | $-9.70M |
| Purchases of Investments | $- | $- | $62.00K | $8.00K | $-29.00K | $-41.00K | $12.52M | $- | $- | $-12.52M | $-101.45M | $-83.86M | $-93.84M | $-136.75M | $-187.98M | $-296.17M | $-140.21M | $-168.32M | $-107.30M | $-130.47M |
| Sales Maturities of Investments | $- | $325.00K | $6.68M | $17.49M | $35.92M | $21.91M | $33.75M | $60.26M | $64.28M | $108.49M | $97.47M | $86.43M | $85.31M | $112.64M | $162.36M | $293.20M | $169.85M | $139.18M | $106.28M | $100.74M |
| Other Investing Activities | $-55.59M | $4.45M | $6.73M | $-8.00K | $29.00K | $41.00K | $-12.38M | $76.00K | $606.00K | $95.97M | $-3.98M | $2.57M | $-8.53M | $-1.29M | $-25.62M | $8.12M | $22.80M | $-33.38M | $-25.07M | $-16.93M |
| Net Cash Used for Investing Activities | $-17.16M | $-33.66M | $-17.52M | $-14.64M | $11.54M | $-8.68M | $6.88M | $19.52M | $93.00M | $81.64M | $-17.10M | $-15.39M | $-39.34M | $-25.41M | $-31.71M | $-60.92M | $22.80M | $-35.73M | $-12.21M | $-42.95M |
| Debt Repayment | $-75.00K | $-98.00K | $- | $- | $- | $- | $- | $-40.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $-1.08M | $1.08M | $13.00K | $1.30M | $79.00K | $1.06M | $-905.00K | $23.00K | $- | $- | $91.00K | $1.22M | $5.57M | $1.05M | $11.83M | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-1.33M | $1.08M | $-81.00K | $1.25M | $-310.00K | $1.06M | $252.00K | $23.00K | $-79.26M | $905.00K | $-1.03M | $1.22M | $5.57M | $1.05M | $10.74M | $10.14M | $7.56M | $5.09M | $1.49M | $8.70M |
| Net Cash Used Provided by Financing Activities | $-1.41M | $979.00K | $13.00K | $1.25M | $-310.00K | $1.06M | $252.00K | $-39.98M | $-79.26M | $905.00K | $-1.03M | $1.22M | $5.57M | $1.05M | $10.74M | $10.14M | $7.56M | $5.09M | $1.49M | $8.70M |
| Effect of Forex Changes on Cash | $-1.93M | $463.00K | $31.00K | $-731.00K | $-7.00K | $205.00K | $-1.99M | $4.66M | $-2.11M | $-5.78M | $-668.00K | $-668.00K | $-4.25M | $-3.17M | $1.12M | $-1.21M | $171.00K | $181.00K | $585.00K | $-1.17M |
| Net Change in Cash | $19.75M | $-50.13M | $9.17M | $-44.33M | $26.93M | $15.59M | $96.11M | $-32.87M | $-7.10M | $62.62M | $1.59M | $-8.24M | $-20.16M | $-4.32M | $2.12M | $-40.38M | $52.92M | $-5.32M | $15.49M | $-15.64M |
| Cash at End of Period | $140.23M | $120.48M | $170.61M | $161.44M | $205.76M | $178.83M | $163.24M | $67.13M | $100.00M | $107.10M | $44.47M | $42.88M | $51.12M | $71.28M | $75.60M | $73.48M | $113.87M | $60.95M | $66.27M | $50.77M |
| Cash at Beginning of Period | $120.48M | $170.61M | $161.44M | $205.76M | $178.83M | $163.24M | $67.13M | $100.00M | $107.10M | $44.47M | $42.88M | $51.12M | $71.28M | $75.60M | $73.48M | $113.87M | $60.95M | $66.27M | $50.77M | $66.41M |
| Operating Cash Flow | $40.25M | $-17.91M | $26.65M | $-30.21M | $15.71M | $23.01M | $90.97M | $-17.07M | $-18.73M | $-14.14M | $20.39M | $6.59M | $17.85M | $23.21M | $21.97M | $11.60M | $22.39M | $25.13M | $25.63M | $19.78M |
| Capital Expenditure | $38.43M | $-38.43M | $-24.25M | $-32.12M | $-24.42M | $-30.63M | $-25.50M | $-15.15M | $-12.11M | $-13.00M | $-12.54M | $-6.66M | $-3.94M | $-1.29M | $-7.32M | $-8.30M | $-6.84M | $-4.25M | $-7.73M | $-3.52M |
| Free Cash Flow | $78.69M | $-56.35M | $2.40M | $-62.33M | $-8.70M | $-7.62M | $65.46M | $-32.22M | $-30.83M | $-27.14M | $7.85M | $-65.00K | $13.91M | $21.91M | $14.65M | $3.29M | $15.55M | $20.89M | $17.90M | $16.26M |
Neogen Dividends
Explore Neogen's dividend history, including dividend yield, payout ratio, and historical payments.
Neogen News
Read the latest news about Neogen, including recent articles, headlines, and updates.
NLRB Withdraws Unfair Labor Practices Claim Against Neogen®
LANSING, Mich. , Feb. 18, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the National Labor Relations Board (NLRB) has withdrawn its unfair labor practices claim against the Company.
Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors
Vertiv Holdings Co. excels with strong AI-related data center demand, projecting 16%-18% organic revenue growth for 2025, and increased profit margins. Chart Industries, Inc. shows robust fundamentals with record revenue and margins, expecting 12% revenue and 18% EBITDA growth in 2025. Intapp, Inc. benefits from strong quarterly results, 17% revenue growth, and a record pipeline, driven by AI product demand and favorable M&A activity.
Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk
LINCOLN, Neb. , Jan. 21, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food security solutions, announced today the launch of Igenity® BCHF to improve overall bovine heart health standards.
Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay
LANSING, Mich. , Jan. 16, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the launch of the new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96).
Exploring Analyst Estimates for Neogen (NEOG) Q2 Earnings, Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Neogen (NEOG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2024.
Neogen® Announces Change to Second-Quarter Earnings Release Date
LANSING, Mich. , Jan. 2, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that, due to U.S. equity markets being closed in observance of the National Day of Mourning for former U.S. President Jimmy Carter, it will now issue its second-quarter earnings release before the opening of the market on Friday, January 10, 2025.
Neogen® Launches Petrifilm® Bacillus cereus Count Plate to Enhance Food Safety Testing Efficiency
LANSING, Mich. , Dec. 17, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, has introduced a new addition to its Petrifilm® product line, the Neogen Petrifilm Bacillus cereus Count Plate.
Neogen® to Participate in the 36th Annual Piper Sandler Healthcare Conference
LANSING, Mich. , Nov. 27, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 36th Annual Piper Sandler Healthcare Conference in New York City on Wednesday, December 4, 2024.
Neogen® To Participate in 2024 UBS Global Healthcare Conference
LANSING, Mich. , Nov. 5, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12.
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation (NEOG) Q1 2025 Earnings Call Transcript
Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for NEOG.